Skanska

Skanska announces that Continuus Pharmaceuticals has cancelled the project to build a pharmaceutical manufacturing facility in Woburn, Massachusetts, USA. The order cancellation is worth USD 112M, about SEK 1.2 billion, which will be recorded in the US order bookings for the second quarter of 2023.